Clinton Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
Clinton Group's DGX Position: Q4 2017 in Review
Clinton Group sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 134,583 shares — an estimated $12.6M sold.
Clinton Group first reported a position in DGX in Q2 2013 and held it in 10 quarters. The position peaked at $12.6M in Q3 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.
- Clinton Group reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
- Clinton Group sold 134,583 Quest Diagnostics shares in Q4 2017, an estimated $12.6M.
- Clinton Group first reported a position in Quest Diagnostics in Q2 2013 and held it in 10 quarters.
- Clinton Group's Quest Diagnostics position peaked at $12.6M in Q3 2017.
- 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.
Based on Clinton Group's 13F filing for Q4 2017, filed 14 Feb 2018.